Paraza Lecture Series -Dr. Richmond Sarpong, University of California Berkeley

Paraza Pharma Inc. is pleased to announce a recent publication

A paper disclosing the discovery of TRPA1 receptor antagonist GDC-6599, a potential first-in-class therapy for respiratory diseases has just been published in the Journal of Medicinal Chemistry. This work was conducted in collaboration with Genentech.

AACR Annual Meeting 2024

Paraza Pharma will be exhibiting at the AACR Annual Meeting 2024 taking place from April 5-10, 2024 at the San Diego Convention Center, San Diego, CA. Come meet us at Booth# 4319.

Annual Drug Discovery Chemistry Conference

The 19th Annual Drug Discovery Chemistry Conference will be held at the Hilton Bayfront in San Diego, CA from April 1- 4, 2024. Paraza will be exhibiting at Booth #504. We look forward to meeting you !

Paraza Pharma Inc. is pleased to announce a recent publication

Amanda Yanez, an undergraduate student from the University of Ottawa, completed  two 4-month internships at Paraza under the supervision of one of our scientists, Alexandria Jeanneret. During her time at Paraza, she conducted research on using metallaphotoredox decarboxylative arylations to form di(hetero)arylmethanes and the results have just been published in Synlett.

Collaboration between Paraza Pharma and Université de Montréal

Paraza is pleased to announce a new collaboration with three research groups of the Department of Chemistry of the Université de Montréal.  Paraza will contribute financially and personally to selected research projects from the groups of Professors Samy Cecioni, Hélène Lebel, and Shawn Collins.

Paraza Pharma is a proud sponsor of QOMSBOC 2023

Paraza Pharma is a proud sponsor of QOMSBOC 2023 which will be held at Concordia University from November 10-12, 2023 at the John Molson School of Business.  We look forward to seeing you there !